"Evidence-Based Medicine Forms ‘Fabric’ Behind Interventional Cardiology" - Melissa Foster
During the past 40 years, new technologies, treatments and techniques in interventional cardiology have faced intense scrutiny and the community has consistently responded with strong scientific evidence, according to Roxana Mehran, MD, director of interventional cardiovascular research and clinical trials at the Zena and Michael A. Weiner Cardiovascular Institute at the Icahn School of Medicine at Mount Sinai. “Evidence-based medicine has been the fabric and cloth that we have woven and stands behind everything we do,” she said during a lecture at the Society for Cardiovascular Angiography and Interventions Scientific Sessions. After the introduction of balloon angioplasty, there were many new developments in the field that withstood close scrutiny, according to Dr. Mehran, including bare-metal stents, which were less than ideal due to high restenosis rates, and the first drug-eluting stents.
- Roxana Mehran, MD, Professor, Medicine, Cardiology, Population Health Science and Policy, Director, Interventional Cardiovascular Research and Clinical Trials, Zena and Michael A. Weiner Cardiovascular Institute, Icahn School of Medicine at Mount Sinai